[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-366416-105":59,"doc-detail-366416-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","circular-rnas-key-regulators-of-paclitaxel-sensitivity-and-resistance-in-cancer-review","Circular RNAs - key regulators of paclitaxel sensitivity and resistance in cancer - review","","Paclitaxel is a cornerstone of cancer therapy, but resistance limits its clinical effectiveness. This review synthesizes evidence that circular RNAs (circRNAs) regulate paclitaxel resistance, functioning as potential biomarkers and therapeutic targets. It organizes circRNA roles in chemoresistance as promoters or suppressors, emphasizing mechanisms including miRNA sponging and protein interactions. The review further highlights epithelial–mesenchymal transition and autophagy modulation, notes context-dependent opposing effects across cancers, and identifies gaps in circRNA network understanding and clinical translation.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/circular-rnas-key-regulators-of-paclitaxel-sensitivity-and-resistance-in-cancer-review/366416/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/circular-rnas-key-regulators-of-paclitaxel-sensitivity-and-resistance-in-cancer-review/366416.png","ImageObject",300,407,{"name":92,"@type":93},"Mabel","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-20","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What problem does the review address regarding paclitaxel therapy?","Question",{"text":112,"@type":113},"Paclitaxel therapy is limited by the development of resistance, which reduces clinical efficacy and contributes to cancer recurrence in treated patients.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How do circular RNAs influence paclitaxel sensitivity and resistance?",{"text":117,"@type":113},"The review describes circRNAs as regulators of chemoresistance, including roles as miRNA sponges and through protein interactions that change drug sensitivity.",{"name":119,"@type":110,"acceptedAnswer":120},"Which downstream pathways are emphasized as being affected by circRNA mechanisms?",{"text":121,"@type":113},"The review highlights epithelial–mesenchymal transition and autophagy modulation as two significant downstream pathways influenced by primary circRNA mechanisms.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},366416,1790738491,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":46,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":31,"preview_page_count":19,"preview_urls":144},7971474920318,"https://ap-avatar.wpscdn.com/avatar/74000ee537e6b0ca360?x-image-process=image/resize,m_fixed,w_180,h_180&k=1788430171632181674","Tajik and Ghafouri‑Fard European Journal  \nEuropean Journal of Medical Research (2025) 30:758  \n[https://doi.org/10.1](https://doi.org/10.1) 186/s40001‑025‑03045‑w of Medical Research  \n REVIEW Open Access  \nCircular RNAs: key regulators of paclitaxel sensitivity and resistance in cancer  \nZahra Tajik1 and Soudeh Ghafouri‑Fard2*  \nAbstract  \nPaclitaxel remains a cornerstone of cancer therapy, yet resistance significantly limits its clinical efficacy. Emerging evidence implicates circular RNAs (circRNAs) as key regulators of paclitaxel resistance, offering potential biomarkers and therapeutic targets. This review synthesizes current knowledge on circRNA‑mediated resistance mechanisms, categorizing their roles as promoters or suppressors of chemoresistance. We highlight two major pathways—miRNA sponging and protein interactions—through which circRNAs alter drug sensitivity. Moreover, we focus on enhance‑ ment of epithelial–mesenchymal transition and modulation of autophagy as two significant downstream pathways influenced by the established primary mechanisms. Notably, our analysis reveals context‑dependent dualities, where certain circRNAs exert opposing effects in different cancers, underscoring the need for tissue‑specific thera‑ peutic strategies. Furthermore, we identify critical gaps in understanding circRNA regulatory networks and their clini‑ cal translatability. By evaluating circRNA signatures associated with paclitaxel response, this review proposes a frame‑ work for biomarker development and combination therapies to circumvent resistance. Our findings emphasize the urgency of functional studies and standardized profiling methods to harness circRNAs for personalized oncology. Keywords RNA, Circular, Paclitaxel, Drug resistance, Neoplasm, RNA, Long noncoding  \nIntroduction  \nCircular RNAs (circRNAs) are noncoding RNAs characterized by single-stranded, covalently closed circular structures that lack 5′ caps and 3′ poly(A) tails. Owing to these characteristics, they are resistant to digestion by ribonucleases, including RNase R and exonuclease, therefore, they have longer half-lives compared with linear mRNAs [1]. They have wide expression in human cells, and their expression sometimes highly surpasses the levels of their linear isomers [2]. Based on their origins, they are categorized into five groups: (1) exon-only circRNAs (EcircRNAs), (2) intron only circRNAs (ciRNA),  \n*Correspondence: Soudeh Ghafouri‑Fard[s.ghafourifard@sbmu.ac.ir](s.ghafourifard@sbmu.ac.ir)  \n1 Student Research Committee, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran  \n2 Department of Medical Genetics, Shahid Beheshti University of Medical Sciences, Tehran, Iran  \n(3) those created byback-splicing of upstream exons and intron retention (EIcircRNA),(4) circRNAs made from gene fusion (f-circRNA), and (5) read-through circRNAs formed by polymerase II (rt-circRNAs). Despite their diverse origins, circRNAs are generally made through head-to-tail back splicing [3].  \nCircRNAs regulate expression of their parental genes, affect alternative splicing, transcription and translation, serve as miRNA sponges, sequester RNA-binding proteins or act as protein scaffolds. They may occasionally be translated into peptides/proteins and make some pseudogenes [4].  \nMost importantly, the recent decade has witnessed the great improvement in the recognition of the role ofcircRNAs in regulating cancer progression and chemoresistance [5, 6]. Through acting as miRNA or protein sponges, interacting with proteins, and serving as regulators of transcription or translation, they affect several important aspects of cell physiology and pathology [6].  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution‑NonCommercial‑NoDerivatives 4.0 International License, which permits any non‑commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to th","cbCaiswmj2kiTTlI","https://ap.wps.com/l/cbCaiswmj2kiTTlI","pdf",1746059,"English","# Abstract\n# Introduction\n## Properties and classification of circular RNAs\n## Biological roles of circRNAs\n## CircRNAs in cancer progression and chemoresistance\n# Paclitaxel and drug resistance mechanisms","[{\"question\":\"What problem does the review address regarding paclitaxel therapy?\",\"answer\":\"Paclitaxel therapy is limited by the development of resistance, which reduces clinical efficacy and contributes to cancer recurrence in treated patients.\"},{\"question\":\"How do circular RNAs influence paclitaxel sensitivity and resistance?\",\"answer\":\"The review describes circRNAs as regulators of chemoresistance, including roles as miRNA sponges and through protein interactions that change drug sensitivity.\"},{\"question\":\"Which downstream pathways are emphasized as being affected by circRNA mechanisms?\",\"answer\":\"The review highlights epithelial–mesenchymal transition and autophagy modulation as two significant downstream pathways influenced by primary circRNA mechanisms.\"}]","Circular RNAs - key regulators of paclitaxel sensitivity and resistance in cancer - review | PDF",1790165459,[145,149,153,157],{"page_no":8,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d9008bbe5d86bed069c7c2ec2cd5a4e9.webp",983,1305,{"page_no":14,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8c9d3ffa384ccc171bfd4bccb15f74af.webp",982,1304,{"page_no":81,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/23d803b53222e10e3297c5b0ad0c7743.webp",981,1303,{"page_no":19,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/21fb6ffe6c7d0e646ed200af621d3aa5.webp",980,1301]